Threshold Crossing by Deep Track Biotechnology

Deep Track Biotechnology Master Fund, Ltd., through a declaration received on February 13, 2026, announced that it had crossed the 5% threshold of voting rights in INVENTIVA on February 12, 2026. Following this transaction, Deep Track now holds 10,825,250 shares, representing 5.24% of the share capital and 4.90% of the voting rights of INVENTIVA. This change resulted from the sale of shares on the market, in accordance with Article L. 233-7 of the French Commercial Code.

Deep Track Biotechnology, a Greenwich, Connecticut-based fund manager, manages this portfolio on behalf of diversified funds. The impact of this sale on INVENTIVA's governance or future strategy remains to be seen. This transaction reflects a strategic realignment of the portfolio under the responsibility of investment manager Deep Track Capital, LP, overseen by Mr. David Kroin.